Related by context. All words. (Click for frequent words.) 78 TEAEs 73 nonfatal MI 73 cerebrovascular events 73 Hypotension 73 HbA 1c levels 72 recurrent VTE 72 severe exacerbations 72 nonvertebral fractures 72 periprocedural 72 Postoperative complications 72 thrombotic events 72 MACCE 72 rebleeding 72 reinfarction 71 Stent thrombosis 71 thromboembolism 71 Erythropoietic therapies may 71 CVD mortality 71 recurrent DVT 71 NNT = 71 recurrent venous thromboembolism 71 oxycodone CR 71 elevated IOP 71 noncardiovascular mortality 71 thromboembolic 71 perioperative mortality 70 FluCAM arm 70 ipsilateral stroke 70 PREZISTA r arm 70 thromboembolic events 70 noncardiac 70 myocardial infarctions 70 nonvertebral fracture 70 coronary stenosis 70 definite stent thrombosis 70 inhospital 70 advanced adenoma 70 morphometric vertebral fractures 70 Febrile neutropenia 70 thromboembolic complications 70 hyperkalemia 70 p = NS 70 TMP SMX 70 elevated ALT 70 generalized edema 69 Operative mortality 69 mmHg diastolic 69 ARCOXIA 69 hypoglycemic episodes 69 hematologic adverse 69 postoperative AF 69 revascularizations 69 events TEAEs 69 Infusion Reactions Severe 69 polyp recurrence 69 binary restenosis 69 peripheral sensory neuropathy 69 hematologic toxicity 69 pyrexia mucositis sepsis febrile 69 ximelagatran 69 endophthalmitis 69 symptomatic VTE 69 LV dysfunction 69 VT VF 69 sustained ventricular tachycardia 69 hypophosphatemia 69 nondiabetic patients 69 recurrent ischemia 69 alanine aminotransferase 69 prolonged QT interval 69 deep venous thromboses 69 myocardial infarction stroke 69 ALT elevation 69 colorectal adenoma 68 TAXUS p value 68 mg BID dose 68 CI #.#-#.# [001] 68 lopinavir r arm 68 tapentadol ER 68 discontinuations due 68 reoperations 68 unstable angina pectoris 68 leucopenia 68 systolic dysfunction 68 postoperative atrial fibrillation 68 leukopenia 68 postoperative complication 68 ARCALYST ® 68 neutropenia dehydration dyspnea 68 laboratory abnormalities 68 carotid stenosis 68 glycated hemoglobin levels 68 VIIBRYD 68 EXJADE 68 extrapyramidal symptoms 68 ATACAND 68 nonfatal stroke 68 PRADAXA #mg 68 β blockers 68 Hb A1C 68 hemorrhagic complications 68 myocardial infarction MI 68 multivariate adjustment 68 confidence interval #.#-#.# 67 syncopal 67 mcg kg REBETOL 67 Complication rates 67 pericardial effusion 67 nadroparin 67 nonfatal myocardial infarction MI 67 baseline serum creatinine 67 microvascular complications 67 severe hypoglycemic 67 intima media thickness 67 serum creatinine levels 67 hypoglycemic events 67 intravesical therapy 67 mcg QD 67 COPD exacerbation 67 aldosterone antagonist 67 psychiatric comorbidities 67 % CI #.#-#.# [007] 67 PLX STROKE targeting 67 #.#/#.# mmHg [001] 67 tirofiban 67 drotrecogin alfa activated 67 rFVIIa 67 XIENCE V PROMUS Stent 67 non valvular atrial 67 HbA1C levels 67 undergoing CABG 67 sternal wound infections 67 febrile neutropenia 67 baseline HbA1c 67 ICD implants 67 events MACE 67 Thrombocytopenia 67 NYHA Class II 67 glomerular filtration 67 receiving XGEVA 67 symptomatic intracranial hemorrhage 67 titrated glipizide 67 postoperative mortality 67 cytopenias 67 subclinical hypothyroidism 67 macroalbuminuria 67 acute myocardial infarctions 67 intracranial hemorrhage ICH 67 neutropaenia 67 stent thromboses 67 systemic embolism 67 VaD 67 anastomotic leak 67 transaminase elevations 67 perioperative complications 67 hypokalemia 67 benazepril 66 SGPT 66 cerebrovascular accident 66 HbA 1c 66 intravitreal injections 66 lipid lowering medications 66 REYATAZ r arm 66 macrovascular events 66 CHD mortality 66 symptomatic intracranial 66 mL/min/#.# m 2 66 neurologic complications 66 gastrointestinal perforations 66 systolic hypertension 66 fatigue asthenia 66 mcg BID 66 vaccinees 66 revascularization procedures 66 salmeterol fluticasone 66 certolizumab 66 paroxysmal AF 66 serum phosphate 66 hepatorenal syndrome 66 beta blocker therapy 66 sotalol 66 cholecystitis 66 x ULN 66 lipid lowering agents 66 NATRECOR ® 66 EDSS scores 66 Serious adverse reactions 66 severe neutropenia 66 invasive aspergillosis 66 advanced adenomas 66 hematological adverse 66 venous thromboembolic events 66 CYPHER ® 66 hypomagnesemia 66 HF hospitalization 66 PASI scores 66 ischemic cardiomyopathy 66 haemorrhagic stroke 66 achieved ACR# 66 Ischemic stroke 66 HBeAg negative patients 66 refractory ischemia 66 lymphocytosis 66 moderate renal impairment 66 ALT flares 66 aspartate aminotransferase AST 66 carotid artery blockage 66 epistaxis 66 aspirin clopidogrel 66 NATRECOR R 66 nonmelanoma skin cancers 66 receiving VICTRELIS 66 intracerebral haemorrhage 66 neutropenia thrombocytopenia 66 octreotide LAR 66 corticosteroid dose 66 left ventricular systolic 66 salmeterol HFA MDI 66 contrast induced nephropathy 66 lymphopenia 66 dalteparin 66 acute cholecystitis 66 incidence ≥ 66 Severe acneform rash 66 angiotensin converting enzyme inhibitors 66 periprocedural MI 66 ocular adverse 65 pulmonary dysfunction 65 aspartate aminotransferase 65 perioperatively 65 ACTEMRA TM 65 HAM D# scores 65 ß blockers 65 hip BMD 65 serum urate 65 atorvastatin #mg 65 serum aminotransferase levels 65 % Confidence Interval 65 repeat revascularization 65 enalapril 65 postoperative morbidity 65 symptomatic hypotension 65 Neutropenia 65 APTIVUS r 65 aminotransferases 65 retrograde ejaculation 65 recurrent UTI 65 retinal vein occlusion 65 myopathy rhabdomyolysis 65 prednisone prednisolone plus 65 nonsignificant difference 65 % CI #.#-#.# [008] 65 induce orthostatic hypotension 65 venous thromboembolisms 65 paresthesias 65 ertapenem 65 QTc prolongation 65 pT3 65 venous thromboembolic disease 65 postintervention 65 BENICAR HCT 65 resuscitated cardiac arrest 65 artery stenosis 65 tachyarrhythmias 65 intracerebral hemorrhages 65 vertebral fracture 65 treatment emergent adverse 65 adjunctive placebo 65 gastrointestinal perforation 65 abdominal adiposity 65 thrombotic complications 65 elevated LDH 65 COPD exacerbations 65 postoperative infections 65 pyelonephritis 65 DES implantation 65 renal dysfunction 65 REMICADE monotherapy 65 intracranial atherosclerosis 65 β blocker 65 sirolimus stent 65 % CI #.#-#.# [001] 65 cardiovascular hospitalizations 65 CHD CVD 65 CR nPR 65 autonomic dysfunction 65 intracerebral hemorrhage 65 intravenous bisphosphonates 65 serum urate levels 65 upper gastrointestinal bleeding 65 myalgia arthralgia 65 treatment emergent AEs 65 severe hypoglycaemia 65 arterial thromboembolism 65 renal toxicity 65 nonselective NSAIDs 65 nonfatal myocardial infarction 65 dysmenorrhoea 65 prednisone prednisolone 65 elevated LDL cholesterol 65 asymptomatic PAD 65 Toxicities 65 p = #.# [003] 65 hepatotoxicity 65 postprocedure 65 hypercalcemia 65 elevated triglyceride levels 65 postoperative delirium 65 TNF antagonist 65 onset diabetes mellitus 65 IOP lowering 65 pooled comparator 65 Ischemic strokes 65 CrCl 65 preserved systolic 65 placebo dexamethasone 65 nasopharyngitis 65 Avandia Actos 65 symptomatic hyponatremia 65 inhospital mortality 65 hepatic failure 65 variceal bleeding 65 CI #.#-#.# [002] 65 hematologic abnormalities 65 overt nephropathy 65 CYPHER Stent 65 gastrointestinal bleeds 64 femoral neck fracture 64 Kaplan Meier estimates 64 Peripheral edema 64 symptomatic carotid stenosis 64 milrinone 64 pericardial effusions 64 PRADAXA 64 noncardiovascular 64 anemia neutropenia 64 nonadherence 64 graft occlusion 64 oral hypoglycemic agents 64 Mitral regurgitation 64 unfractionated heparin UFH 64 NSTEMI 64 thrombocytopenia neutropenia 64 dapagliflozin plus 64 multivariable adjusted 64 haematologic 64 ARIXTRA 64 fluvoxamine Luvox 64 rizatriptan 64 ejection fractions 64 detrusor overactivity 64 confidence intervals CIs 64 syncope fainting 64 oral antidiabetes 64 suboptimal adherence 64 poor metabolizers 64 preserved ejection fraction 64 endometrial hyperplasia 64 Pulmonary embolism 64 neurodevelopmental impairment 64 serum estradiol 64 acarbose 64 renal impairment 64 dose Iluvien 64 hemoptysis 64 diastolic BP 64 LVSD 64 mild renal insufficiency 64 Arch Intern Med 64 idraparinux 64 CIMZIA ™ 64 % CI #.#-#.# [005] 64 oxycodone IR 64 mCRC acneform rash 64 labetalol 64 oxygen desaturation 64 nondiabetics 64 sensory neuropathy 64 leukocyte count 64 histologic subtype 64 FOLFOX4 64 thyrotropin levels 64 RLAI 64 Aortic stenosis 64 antiarrhythmic drug 64 corneal infection 64 neutrophil counts 64 atrophic gastritis 64 ischemic strokes 64 tapentadol IR 64 Drug eluting stent 64 thrombocytopenic 64 P = .# 64 myocardial infarction ventricular fibrillation 64 thromboses 64 fatal myocardial infarction 64 ischemia driven 64 intraventricular hemorrhage 64 VTEs 64 thrombophlebitis 64 zolmitriptan 64 Renal dysfunction 64 proliferative diabetic retinopathy 64 coronary revascularization 64 #.#mg/dL 64 relapsed MM 64 venlafaxine Effexor 64 ventricular tachycardia VT 64 -#.# mg dL [002] 64 diastolic blood pressures 64 eplerenone 64 venous blood clots 64 vWD 64 symptomatic pulmonary embolism 64 diabetic kidney 64 asymptomatic carotid stenosis 64 adenoma recurrence 64 left ventricular dysfunction 64 headache abdominal pain 64 annualized relapse 64 ventricular dysfunction 64 severe hypoglycemia 64 ventricular tachyarrhythmia 64 ischemic complications 64 conventional antipsychotics 64 hypoxemia 64 primidone 64 chlorambucil 64 nicardipine 64 SSRI SNRI 64 microbiological eradication 64 symptomatic aortic stenosis 64 Prehypertension 64 malignant neoplasm 64 hypocalcemia 64 microvascular disease 64 receiving PEGINTRON 64 Renal impairment 64 Orthostatic hypotension 64 plasma homocysteine 64 diameter stenosis 64 serum potassium 64 cardiovascular hospitalization 64 nontraumatic 64 hyperacute 64 adjunctive ABILIFY 64 angiographic restenosis 64 affective psychoses 64 angina pectoris 64 ruptured aneurysms 64 fibrinolysis 64 adverse reactions occurring 64 mild renal impairment 64 â ‰ ¥ 64 rosuvastatin Crestor 64 serum phosphate levels 64 nonsignificant 64 ICD implantation 64 atheroma volume 64 androgen suppression 64 dysglycemia 64 anemia hemoglobin 64 oral allopurinol 64 linaclotide treated 64 #mmHg [001] 64 renal insufficiency 64 intra abdominal abscess 63 dizziness nausea diarrhea 63 angiotensin II receptor blockers 63 mm Hg systolic 63 elevated serum creatinine 63 glycated hemoglobin HbA1c 63 retransplantation 63 valvular disease 63 hypoperfusion 63 coronary revascularization procedures 63 nocturnal hypoglycemia 63 anaphylactic reactions bronchospasm 63 cardioembolic stroke 63 postoperative bleeding 63 oral diclofenac 63 necrotizing pancreatitis 63 Hemorrhagic stroke 63 mm Hg diastolic 63 OSAHS 63 torsade de pointes 63 malperfusion 63 dose dabigatran 63 biologic DMARD 63 hypertension diabetes mellitus 63 virologic failures 63 loop diuretics 63 creatine kinase MB 63 gout flares 63 subtrochanteric 63 sinus node dysfunction 63 albumin excretion rate 63 ICD shocks 63 TAXUS Stent 63 Severe hypoglycemia 63 plus aztreonam 63 Ishak fibrosis score 63 thrombosis embolism 63 TYSABRI treated 63 aortic regurgitation 63 bacterial prostatitis 63 postoperative pulmonary 63 angina chest 63 % AST SGOT 63 tumor lysis syndrome 63 chlorthalidone 63 neurologic sequelae 63 neurologic dysfunction 63 hepatic dysfunction 63 HBeAg seroconversion 63 umol L 63 cardiac dysfunction 63 metoprolol tartrate 63 receiving Vectibix monotherapy 63 lung resections 63 proximal DVT 63 ischemic cerebrovascular 63 mmHg systolic 63 INVEGA ® 63 Adjuvant chemotherapy 63 fluid overload 63 atherogenic dyslipidemia 63 confidence interval CI 63 Venous thromboembolism 63 HIV HCV coinfected 63 Index CDAI 63 Intracerebral hemorrhage 63 arterial thromboembolic 63 gadobutrol 63 CP CPPS 63 nausea dizziness vomiting 63 reinterventions 63 lowest tertile 63 mucosal inflammation 63 left ventricular hypertrophy 63 serum homocysteine 63 hemorrhagic strokes 63 HMG CoA reductase inhibitors 63 cerebral infarction 63 stable angina 63 hypoglycaemic episodes 63 isolated systolic hypertension 63 Hypocalcemia 63 subclinical hyperthyroidism 63 mmol liter 63 NYHA functional class 63 Lactic acidosis 63 oral hypoglycemic agent 63 vertebral fractures 63 intraoperative complications 63 serum sodium levels 63 decompensated heart failure 63 nephrotoxicity 63 thromboembolic disease 63 dermatologic toxicities 63 Thrombotic events 63 aldosterone antagonists 63 elevated lipase 63 onset atrial fibrillation 63 preintervention 63 revascularization procedure 63 splenectomized patients 63 severe NCI CTC 63 familial AF 63 sinus bradycardia 63 ARB telmisartan 63 mmol l 63 microbleeds 63 SRBD 63 olmesartan 63 hemoglobin A1c levels 63 ALT elevations 63 antithrombotic therapy 63 lipid lowering drugs 63 del 5q MDS 63 constipation nausea 63 hsCRP levels 63 bezafibrate 63 irbesartan 63 de ath 63 underwent CABG 63 elevated uric acid 63 alfuzosin 63 FOLFIRI alone 63 elevated transaminases 63 venous thrombosis 63 pulmonary capillary wedge 63 Endothelial dysfunction 63 atrioventricular block 63 % CI #.#-#.# [004] 63 renal artery stenosis 63 cirrhotic patients 63 venlafaxine XR 63 ULORIC 63 bacteriuria 63 Treatment emergent adverse 63 serologically active patients 63 triglyceride concentrations 63 heparin induced thrombocytopenia 63 MULTAQ 63 milliliters mL 63 lower extremity amputation 63 HbA 1C 63 oral antidiabetic medication 63 patients undergoing CABG 63 Serum creatinine 63 orthostatic hypotension 63 CIN3 63 low dose Iluvien 63 carotid artery stenosis 63 endarterectomy 63 primary aldosteronism 63 macrovascular 63 % CI #.#-#.# [006] 63 fragility fracture 63 unresectable HCC 63 virologic failure 63 PSA nadir 63 recurrent atrial fibrillation 63 haemorrhagic strokes 63 receiving prophylactic anticoagulation 63 oral prednisolone 63 diastolic hypertension 63 malignant neoplasms 63 lamivudine monotherapy 63 CABG coronary artery 63 systemic corticosteroid 63 Lupuzor ™ 63 LVEF 63 cerebral vasospasm 63 maximal doses 63 receiving ISENTRESS 63 BYSTOLIC 63 metformin monotherapy 63 antithrombotics 63 arterial occlusion 63 pretest probability 63 infarctions 63 clinically meaningful reductions 63 nonischemic 63 paroxysmal atrial fibrillation 63 amenorrhoea 63 acute coronary syndromes ACS 63 CDI recurrence 63 receiving INTRON 63 NMIBC 63 typical antipsychotics 63 infective endocarditis 63 renal scarring 63 EDARBI 63 XIENCE V vs. 63 cerebral oxygenation 63 CCyR 63 % CI #.#-#.# [003] 63 myocardial fibrosis 63 TURBT 63 neovascular glaucoma 63 Doxil ® 63 anticoagulant warfarin 63 IIIa inhibitors 63 TAVR 62 Clinically significant 62 external genital lesions 62 untreated OSA 62 AST ALT 62 hepatic enzymes 62 impaired renal 62 nadolol 62 FDA defined valvulopathy 62 atherothrombotic disease 62 Hazard Ratio = 62 abdominal distention 62 MMSE scores 62 calcified plaques 62 hypopneas 62 uncontrolled hypertension 62 A1c levels 62 symptomatic intracerebral hemorrhage 62 serum uric acid 62 paroxetine Paxil 62 mg p = 62 aneurysmal subarachnoid hemorrhage 62 Platelet counts 62 venous thromboembolism 62 DVT PE 62 fetal chromosomal 62 Hyperkalemia 62 Subarachnoid hemorrhage 62 candidemia 62 IFN alfa 62 beta carotene supplementation 62 cerebrovascular accidents 62 Primary endpoints 62 urolithiasis 62 glycosylated hemoglobin HbA1c 62 hyperhomocysteinemia 62 hyperparathyroidism 62 primary percutaneous coronary 62 alanine aminotransferase ALT 62 preoperative PSA 62 IPAH 62 timepoints 62 severe renal impairment 62 adverse cytogenetics 62 infliximab monotherapy 62 ticlopidine 62 mcg albinterferon alfa 2b 62 cardiac tamponade 62 hematological toxicity 62 p = .# [001] 62 lumiracoxib 62 hypertension congestive heart 62 silent ischemia 62 pCR 62 Folfox 62 lipid elevations 62 hip resurfacing arthroplasty 62 Myelosuppression 62 oral Hycamtin 62 transfusion syndrome 62 XIENCE V demonstrated 62 Hypoglycemia 62 hyperbilirubinemia 62 systemic hypotension 62 postoperative infection 62 pruritus rash 62 DAS# remission 62 IIIa inhibitor 62 8mg/kg 62 alteplase 62 vestibular dysfunction 62 cystoid macular edema 62 invasive carcinomas 62 TAXUS Express Stent 62 HGPIN 62 segment binary restenosis 62 intracranial bleeding 62 ACE Inhibitors 62 thromboembolic disorders 62 dermatologic reactions 62 metabolic acidosis 62 somnolence dizziness 62 mmHg p = 62 tolterodine ER 62 ECG abnormalities 62 imipenem 62 Thrombolysis 62 corticosteroid therapy 62 antiplatelet medications 62 postoperative complications 62 rectal tenesmus 62 quetiapine risperidone 62 elevated hsCRP 62 statin monotherapy 62 loop diuretic 62 mediastinitis 62 heFH 62 atherothrombotic events 62 hallucinations dyskinesia 62 hemoglobin A1c HbA1c 62 conjunctival hyperemia 62 receiving VELCADE 62 non hematological toxicities 62 CTEPH 62 Tardive dyskinesia 62 nocturnal hypoglycaemia 62 acute aortic dissection 62 myocardial infarctions MIs 62 NYHA Class III 62 spinal cord compression 62 urine albumin 62 fluticasone salmeterol 62 tipranavir r 62 elevated creatinine 62 beta blockers ACE inhibitors 62 mEq L 62 nonhematologic adverse reactions 62 imiquimod cream 62 p = .# [002] 62 intensive statin therapy 62 nonmelanoma skin cancer 62 DETROL LA 62 HOMA IR 62 elevated fasting glucose 62 deep venous thrombosis 62 glycoprotein IIb IIIa inhibitors 62 CNS systemic embolism 62 argatroban 62 prolactin levels 62 atherothrombotic 62 intact parathyroid hormone 62 Heavy menstrual bleeding 62 enzyme elevations 62 Discontinuations due 62 asthma exacerbation 62 cardiovascular mortality 62 rimonabant #mg 62 receiving golimumab 62 trimethoprim sulfamethoxazole 62 ONGLYZA saxagliptin 62 triglyceride concentration 62 angioneurotic edema 62 cobiprostone 62 isoproterenol 62 conjugated equine estrogen 62 anthracycline taxane 62 clinically evaluable patients 62 posaconazole 62 simvastatin ezetimibe 62 perimenopausal women 62 Warfarin Coumadin 62 QTcF 62 hypotension 62 adrenal insufficiency 62 transferrin saturation 62 Ejection Fraction 62 Adenomas 62 ecchymosis 62 nonfasting triglycerides 62 lower extremity amputations 62 AA Amyloidosis 62 Fasting blood glucose 62 interstitial pneumonia 62 gastric cardia 62 mycophenolate mofetil 62 NOLVADEX 62 atypical ductal hyperplasia 62 tolvaptan 62 echocardiographic parameters 62 Taxus Stent 62 coronary stenoses 62 intracranial stenosis 62 adenomatous polyps 62 HBV infections 62 ACUITY trial 62 severe hypersensitivity reactions 62 hypercholesterolaemia 62 pheochromocytoma 62 peripheral edema 62 composite endpoint 62 nephrolithiasis 62 Critical limb ischemia 62 serum parathyroid hormone 62 Hip fracture 62 CIMZIA TM certolizumab pegol 62 SCr 62 optic neuropathy 62 serum BDNF 62 adverse reactions incidence 62 locoregional recurrence 62 LOVENOX 62 alemtuzumab treated 62 antiphospholipid syndrome 62 Adverse events 62 5-FU/LV 62 #mg BID [001] 62 intraocular pressure IOP 62 ventricular fibrillation VF 62 complete cytogenetic response 62 Hypokalemia 62 colorectal adenomas 62 wound dehiscence 62 rhythm disturbances 62 KRAS mutations occur 62 variceal hemorrhage 62 torsades de pointes 62 curative resection 62 ropivacaine 62 placebo fluoxetine 62 OAB symptoms 62 akathisia 62 dysrhythmias 62 angina myocardial infarction 62 DOXIL 62 hyperlipemia 62 myocardial reperfusion 62 warfarin sodium 62 abciximab 62 apnea hypopnea 62 terazosin 62 arthralgias 62 impaired glucose metabolism 62 moderately emetogenic 62 serum triglycerides 62 thromboprophylaxis 62 g dl 62 liver transaminases 62 tibolone 62 MCyR 62 achieving PASI 62 carotid endarterectomy 62 CsA 62 pulmonary embolus 62 oral olanzapine 62 QT prolongation 62 prospectively stratified 62 serum ALT 61 RYGB 61 bridging fibrosis 61 Postoperative 61 nonfatal cardiovascular 61 macrovascular disease 61 failure ADHF 61 TNF blocker therapy 61 severe rotavirus gastroenteritis 61 events SAEs 61 dose statin therapy 61 events AEs 61 ACR# ACR# 61 atazanavir ritonavir 61 ribavirin therapy 61 neurologic deficits 61 affective psychosis 61 hypopituitarism 61 ischemic lesions 61 neutropenic sepsis 61 highest quintile 61 asthma exacerbations 61 mean baseline A1C 61 cardiovascular ischemic 61 abacavir lamivudine 61 hyperphenylalaninemia HPA due 61 aged ≥ 61 nmol l 61 p ≤ 61 glyburide 61 leiomyomas 61 carotid endarterectomy CEA 61 gastrointestinal toxicity 61 paroxetine sertraline 61 hepatitis C genotype 61 Polycystic ovary syndrome PCOS 61 atrioventricular valve 61 PEGINTRON TM 61 gastrointestinal adverse reactions 61 macular edema secondary 61 somnolence sedation 61 Events MACE 61 plus methotrexate 61 GI toxicity 61 Ramipril 61 urate lowering therapy 61 oxcarbazepine 61 Ischemic 61 troponin T 61 Crohn Disease Activity 61 stomatitis pharyngitis 61 concomitant AEDs 61 CI -#.# 61 bivalirudin monotherapy 61 Zometa hazard 61 Pulmonary hypertension 61 HbA1c levels 61 hypertensive disorders 61 GP IIb IIIa inhibitors 61 pulmonary embolism PE 61 Mg Uk 61 CIN3 + 61 comorbid disorders 61 nonfasting triglyceride levels 61 microalbuminuria 61 Stomatitis 61 generalized tonic clonic seizures 61 GnRH agonists 61 fluvastatin 61 LNG IUS 61 #mg/dl 61 desvenlafaxine succinate 61 systolic blood pressures 61 pegaptanib 61 #q# deletion syndrome 61 ADHF 61 PENTASA 61 DLTs 61 HBeAg positive patients 61 droperidol 61 HBeAg negative 61 recurrent coronary 61 metformin accumulation 61 elevated liver enzymes 61 de aths 61 myocardial infarction 61 dopaminergic therapy 61 bronchopulmonary dysplasia 61 coronary insufficiency 61 methotrexate monotherapy 61 Non inferiority 61 Aprotinin 61 fraction LVEF 61 syncope 61 myalgia 61 mitral insufficiency 61 Carotid endarterectomy 61 mcg linaclotide